Table 4.
Comparison of adverse reactions [n(%)].
| Dizziness | Fatigue | Constipation | Nausea | Total incidence (%) | |
|---|---|---|---|---|---|
| Observation group (n = 30) | 1 | 1 | 0 | 1 | 3 (10%) |
| Experimental group (n = 30) | 0 | 2 | 1 | 1 | 4 (13%) |
| x 2 | — | — | — | — | 0.162 |
| P | — | — | — | — | 0.688 |
Comparison of adverse reactions [n(%)].
| Dizziness | Fatigue | Constipation | Nausea | Total incidence (%) | |
|---|---|---|---|---|---|
| Observation group (n = 30) | 1 | 1 | 0 | 1 | 3 (10%) |
| Experimental group (n = 30) | 0 | 2 | 1 | 1 | 4 (13%) |
| x 2 | — | — | — | — | 0.162 |
| P | — | — | — | — | 0.688 |